The 3 analysts offering 12-month price forecasts for Forte Biosciences Inc have a median target of 3.50, with a high estimate of 90.00 and a low estimate of 3.00. The median estimate represents a +25.90% increase from the last price of 2.78.
The current consensus among 4 polled investment analysts is to Hold stock in Forte Biosciences Inc. This rating has held steady since September, when it was unchanged from a Hold rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.36
Reporting Date Nov 15
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.